Ultragenyx Pharmaceutical Inc

Company Snapshot
60 Leveroni Court
Novato, CA 94949
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 1,311
https://www.ultragenyx.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$264,901,000
$335,398,000
$335,009,000
Operating Income
($330,116,000)
($381,737,000)
($648,919,000)
Net Income
($186,566,000)
($454,025,000)
($707,421,000)
2020
Gross Profit
$264,901,000
Operating Income
($330,116,000)
Net Income
($186,566,000)
2021
Gross Profit
$335,398,000
Operating Income
($381,737,000)
Net Income
($454,025,000)
2022
Gross Profit
$335,009,000
Operating Income
($648,919,000)
Net Income
($707,421,000)
The above data on Ultragenyx Pharmaceutical Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Emil Kakkis
Director, President, Chief Executive Officer and Principal Financial Officer
$1,354,154
$10,773,976
$12,200
$12,140,330
Emil Kakkis
$12,140,330
Director, President, Chief Executive Officer and Principal Financial Officer
Mardi Dier
Executive Vice President and Chief Financial Officer
$607,346
$3,820,918
$8,492
$4,436,756
Mardi Dier
$4,436,756
Executive Vice President and Chief Financial Officer
Camille Bedrosian
Chief Medical Officer and Executive Vice President
$842,750
$2,900,318
$12,200
$3,755,268
Camille Bedrosian
$3,755,268
Chief Medical Officer and Executive Vice President
John Pinion
Chief Quality Officer and Executive Vice President Translational Sciences
$793,993
$2,900,318
$12,200
$3,706,511
John Pinion
$3,706,511
Chief Quality Officer and Executive Vice President Translational Sciences
Amrit Ray
Director
$41,000
$1,200,598
$0
$1,241,598
Amrit Ray
$1,241,598
Director
Ultragenyx Pharmaceutical Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us